Price Chart

Profile

Tilray is a Canadian producer that cultivates and sells medical and recreational cannabis. In 2021, legacy Aphria acquired legacy Tilray in a reverse merger and renamed itself Tilray. The bulk of its sales are in Canada and in the international medical cannabis export market. U.S. exposure consists of CBD products and alcohol.
URL https://www.tilray.com
Investor Relations URL https://ir.tilray.com/
HQ State/Province Ontario
Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
Equity Style Mid Cap/Value
Next Earnings Release Oct. 04, 2023
Last Earnings Release Jul. 26, 2023
Next Ex-Dividend Date N/A
Last Ex-Dividend Date N/A

Profile

Tilray is a Canadian producer that cultivates and sells medical and recreational cannabis. In 2021, legacy Aphria acquired legacy Tilray in a reverse merger and renamed itself Tilray. The bulk of its sales are in Canada and in the international medical cannabis export market. U.S. exposure consists of CBD products and alcohol.
URL https://www.tilray.com
Investor Relations URL https://ir.tilray.com/
HQ State/Province Ontario
Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
Equity Style Mid Cap/Value
Next Earnings Release Oct. 04, 2023
Last Earnings Release Jul. 26, 2023
Next Ex-Dividend Date N/A
Last Ex-Dividend Date N/A